Purchase Articles
Showing 1–16 of 136 results
-
Evaluation of the PMPRB regulatory performance on price review for new patented drugs in Canada, 2008-2021
$0.00 Add to cart -
Herceptin® treatments in hospital and at CLSCs for breast cancer patients in Quebec: comparative analysis of costs and care trajectories.
$40.00 Add to cart -
Traitements d’Herceptin© à l’hôpital et en CLSC pour les patientes atteintes de cancer du sein au Québec: analyse comparative des coûts et des trajectoires de soins.
$40.00 Add to cart -
New cancer drugs in Canada 2012 to 2021: an economic analysis of cost, benefit, availability, and public insurance coverage.
$0.00 Add to cart -
Economic burden of cardiomyopathy in Canada 2018 to 2021: opportunity for cost avoidance through pharmaceutical innovation.
$0.00 Add to cart -
Policy approaches for increasing participation with personal health information and data sharing (HIDS)
$40.00 Add to cart -
An Evaluation of Access and Policy Initiatives for Breast Cancer Screening in Ontario
$40.00 Add to cart -
Toward a Policy Framework for Sustainable Rural Obstetrics and Surgical Care in Canada
$40.00 Add to cart -
Canada falls behind in new drug submissions compared with the United States and Europe
$40.00 Add to cart -
QALYs and Value Assessment
$40.00 Add to cart -
Healthcare’s search for “wellness”: How bioethics reduces burnout among health professionals
$40.00 Add to cart -
Projected Ontario budget savings from reduced long-term care utilization due to a disease-modifying Alzheimer’s treatment
$40.00 Add to cart -
Integration within Long-Term Care: A Comparative Analysis of Nova Scotia and British Columbia
$40.00 Add to cart -
Effect of amended Patented Medicine Regulations on industry decisions to launch new drugs in Canada
$0.00 Add to cart -
Opportunities to improve health care processes and services outcomes in Canada
$40.00 Add to cart -
Patented Medicines Expenditure in Canada 1990–2020 7th Edition
$0.00 Add to cart